ABSTRACT
Statines are first choice medications for hypercholesterolemia and combined hyperlipidemia of varying severity in wide population of patients. Atorvastatine is one of the most effective statines. In Russia, Atorvastatine is represented by nearly twenty drugs most of which are generics. The article covers data on efficiency, safety and good tolerance of Liptonorm--a generic Atorvastatine.
Subject(s)
Atorvastatin/pharmacology , Cardiovascular Diseases/blood , Cardiovascular Diseases/drug therapy , Drugs, Generic/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Aged , Atorvastatin/administration & dosage , Atorvastatin/adverse effects , Drugs, Generic/administration & dosage , Drugs, Generic/adverse effects , Female , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage , Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects , Male , Middle Aged , Risk , RussiaABSTRACT
Community-acquired pneumonia is one of prevalent infectious respiratory diseases. Adequate treatment of community-acquired pneumonia, with consideration of the disease severity and microbial resistence, remains extremely topical. The article covers contemporary views of community-acquired pneumonia treatment standards. The authors described results of personal research aimed to study antibacterial treatment for community-acquired pneumonia on outpatient basis over 2004-2012, evaluated correspondence of the treatment to the national clinical recommendations.
